{
    "Trade/Device Name(s)": [
        "VIDAS H. pylori IgG",
        "VIDAS 3",
        "VIDAS Lyme IgG II",
        "VIDAS RUB IgG",
        "VIDAS TOXO M",
        "VIDAS Human Chorionic Gonadotropin",
        "VIDAS T4",
        "VIDAS Testosterone",
        "VIDAS TSH",
        "VIDAS D-Dimer Exclusion II"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K141133",
    "Predicate Device Reference 510(k) Number(s)": [
        "K001460",
        "K891385",
        "K122986",
        "K080766",
        "K923166",
        "K921302",
        "K926393",
        "K021326",
        "K921816",
        "K112818"
    ],
    "Regulatory Class": "Class I, Class II",
    "Product Code(s)": [
        "LYR",
        "JJE",
        "LSR",
        "LFX",
        "LGD",
        "DHA",
        "KLI",
        "CDZ",
        "JLW",
        "DAP"
    ],
    "Summary Letter Date": "June 15, 2015",
    "Summary Letter Received Date": "June 16, 2015",
    "Submission Date": "July 6, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.3110",
        "21 CFR 862.2160",
        "21 CFR 866.3830",
        "21 CFR 866.3510",
        "21 CFR 866.3780",
        "21 CFR 862.1155",
        "21 CFR 862.1700",
        "21 CFR 862.1680",
        "21 CFR 862.1690",
        "21 CFR 864.7320"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents",
        "Analyzer, chemistry (photometric, discrete), for clinical use",
        "Treponema pallidum treponemal test reagents",
        "Rubella virus serological reagents",
        "Toxoplasma gondii serological reagents",
        "Human chorionic gonadotropin (HCG) test system",
        "Total thyroxine test system",
        "Testosterone test system",
        "Thyroid stimulating hormone test system",
        "Fibrinogen and fibrin split products, antigen, antiserum, control"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "clinical chemistry",
        "hematology"
    ],
    "Analyte(s)": [
        "anti-Helicobacter pylori IgG",
        "human IgG antibodies to Borrelia burgdorferi",
        "IgG antibodies to rubella virus",
        "anti-Toxoplasma gondii IgM",
        "human Chorionic Gonadotropin (hCG)",
        "thyroxine (T4)",
        "total testosterone",
        "thyroid stimulating hormone (TSH)",
        "fibrin degradation products (D-Dimer)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Plasma (sodium citrate, CTAD)"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Sodium heparin tube",
        "Lithium heparin tube",
        "Plain or separation gel",
        "Heparin tube",
        "Sodium citrate tube",
        "CTAD tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VIDAS",
        "miniVIDAS",
        "VIDAS 3"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked fluorescent immunoassay (ELFA)",
        "Enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Sandwich immunoassay",
        "Competition immunoassay",
        "Indirect EIA",
        "Immunocapture",
        "Quantitative measurement",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Instrument",
        "Reagent",
        "Kit",
        "Calibrator",
        "Control",
        "Consumable",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for the bioM\u00e9rieux VIDAS family of automated immunoassays and analyzer system, including VIDAS 3 and multiple qualitative/quantitative assays using ELFA technology.",
    "Indications for Use Summary": "Automated immunoassay system and assays for qualitative or quantitative detection of specified analytes in human serum or plasma, aiding diagnosis and management of infectious, endocrine, and hematologic conditions in professional laboratory settings.",
    "fda_folder": "Microbiology"
}